Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

22.57
+0.74003.39%
Post-market: 22.570.00000.00%16:04 EDT
Volume:5.06M
Turnover:111.02M
Market Cap:3.81B
PE:-26.87
High:22.68
Open:21.57
Low:20.98
Close:21.83
52wk High:34.39
52wk Low:6.69
Shares:169.00M
Float Shares:121.00M
Volume Ratio:1.42
T/O Rate:4.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8400
EPS(LYR):-0.8746
ROE:-21.34%
ROA:-12.99%
PB:3.72
PE(LYR):-25.81

Loading ...

Tango Therapeutics President, R&D Crystal Adam Disposes of USD 661,799 in Common Shares

Reuters
·
Oct 06

Tango Therapeutics Principal Accounting Officer Jessica Newcomb Disposes of USD 196,558.19 in Common Shares

Reuters
·
Sep 25

Tango Therapeutics Grants New Hire Stock Option for 146,500 Shares at $22.35

Reuters
·
Sep 04

Tango Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 04

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04

Tango Therapeutics President, R&D Crystal Adam Disposes of 27,000 Common Shares Worth $603,909

Reuters
·
Sep 04

Tango Therapeutics (TNGX) Stock Looks Stretched After Its 236% Run

Simply Wall St.
·
Sep 02

Tango Therapeutics Management to Join Fireside Chat at Cantor Global Healthcare Conference

Reuters
·
Sep 01

Tango Therapeutics (TNGX) Is Getting Fresh Attention, What Are Investors Looking At?

Simply Wall St.
·
Aug 14

Tango Therapeutics Ajukan Program Penjualan Saham At-the-Market Hingga USD 400 Juta

Reuters
·
Aug 12

Tango Therapeutics - Files Prospectus to Sell up to $400 Mln in Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 12

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

Tango Therapeutics Q2 Net Loss Widens to $55.3 Million; G&A Expenses Climb 99% to $22.6 Million

Reuters
·
Aug 11

Earnings Flash (TNGX) Tango Therapeutics Posts Q2 Loss $0.37 a Share, vs. FactSet Est of $0.32 Loss

MT Newswires Live
·
Aug 11

Tango Therapeutics Q2 Net Income USD -55.341 Million

THOMSON REUTERS
·
Aug 11

Tango Therapeutics Q2 Basic EPS USD -0.37

THOMSON REUTERS
·
Aug 11

Press Release: Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Dow Jones
·
Aug 11

U.S. Earnings Preview: Before Market Open Aug. 11

Dow Jones
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11